| Oct 24 |
Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024
|
| Oct 18 |
Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease
|
| Sep 10 |
Seth Klarman's Complete Exit from Theravance Biopharma Inc
|
| Sep 6 |
Why Is Madrigal (MDGL) Up 1% Since Last Earnings Report?
|
| Sep 6 |
Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation
|
| Sep 4 |
Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?
|
| Aug 14 |
Seth Klarman's Strategic Reduction in Theravance Biopharma Inc
|
| Aug 14 |
Klarman's Baupost adds WilScot, Capri, exits Altice USA, among others
|
| Aug 10 |
Need To Know: Analysts Just Made A Substantial Cut To Their Theravance Biopharma, Inc. (NASDAQ:TBPH) Estimates
|
| Aug 7 |
Theravance Biopharma Second Quarter 2024 Earnings: Misses Expectations
|
